Pharmacokinetics of recombinant factor VIII (Kogenate‐FS®) in children and causes of inter‐patient pharmacokinetic variability
- 18 September 2006
- journal article
- Published by Wiley in Haemophilia
- Vol. 12 (s4), 40-49
- https://doi.org/10.1111/j.1365-2516.2006.01333.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Use of pharmacokinetics in the coagulation factor treatment of patients with haemophiliaHaemophilia, 2005
- Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and ChildrenNew England Journal of Medicine, 2003
- Pharmacokinetics of Coagulation FactorsClinical Pharmacokinetics, 2001
- Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in ItalyHaemophilia, 2000
- Improved cost‐effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia AHaemophilia, 1997
- Inter‐individual variation in half‐life of infused recombinant factor VIII is related to pre‐infusion von Willebrand factor antigen levelsBritish Journal of Haematology, 1995
- Pharmacokinetic dosing in prophylactic treatment of hemophilia AEuropean Journal of Haematology, 1993
- Clinical Pharmacokinetics of Factor VIII in Patients with Classic HaemophiliaClinical Pharmacokinetics, 1987
- Kinetic evaluation of four Factor VIII concentrates by model‐independent methodsScandinavian Journal of Haematology, 1985
- Effect of height and weight on the in vivo recovery of transfused factor VIII C.Journal of Clinical Pathology, 1982